MOVE Research group
Ixelles-Elsene, Brussels Capital, 1050, Belgium
Location status: Recruiting
NCT Number: NCT06808399
Distance running is one of the most popular and most accessible ways to engage in physical activity. Although distance running offers numerous health-related benefits and protects against noncommunicable diseases (e.g., type 2 diabetic, obesity, hypertension), research has indicated a high prevalence of running-related injuries with a more pronounced incidence among novice runners (i.e., 17.8 injuries per 1000h) compared to their highly trained peers (i.e., 7.2 injuries per 1000h).
Interlimb asymmetry has previously been related to higher injury risk as well as to impaired sports performances. Nevertheless, to date, research on the degree and evolution of functional asymmetry (e.g., unequal strength between limbs) in distance runners is scarce and the role of functional asymmetries in running performance and running-related injuries remains unclear. Moreover, and despite the great number of unilateral tests available in the literature, there currently exists no reliable and run-specific field-based test battery to examine the degree of lower limb asymmetry in distance runners. Therefore, this study aims to assess the test-retest, intra- and inter-rater reliability of a newly created running-specific field-based test battery to assess the presence and degree of functional lower limb asymmetry among novice, moderatly and highly trained distance runners as well as a control group of non-athletes. The second objective is to assess the association between inter-limb asymmetry and running performance.
Interested in participating?
Request Info20 year–50 year
All sexes
Observational
Ixelles-Elsene, Brussels Capital, 1050, Belgium
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Moderately-trained runners:
Exclusion criteria
Time frame: Baseline
Measured using dual-energy X-ray absorptiometry.
Time frame: Baseline
Measured using dual-energy X-ray absorptiometry.
Time frame: Baseline
Measured using dual-energy X-ray absorptiometry.
Time frame: Baseline
Measured using bioelectrical impedance analysis.
Time frame: Baseline
Measured using bioelectrical impedance analysis.
Time frame: Baseline
Measured using bioelectrical impedance analysis.
Time frame: Baseline
Measured using bioelectrical impedance analysis.
Time frame: Baseline
Measured using bioelectrical impedance analysis.
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
Measured using an Optojump device
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
Measured using an Optojump device
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
The maximal dorsiflexion range of motion (cm from a wall) will be measured with tape measure.
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
The side bridge endurance test will be carried out in which, the participants will lie on one side of the body fully extended (i.e., hip and torso at 0°) in a plank position with the feet elevated on a 15-cm step and with the superior feet placed in front. The participants will be instructed to lift the hips until the body is in straight position with the arms folded across the chest. The time until a drop (lasting more than 3s) of the hips from the optimal position will manually be recorded. To control for a full range of motion upon the execution of this muscle capacity tests, a reference dowel will be used to indiciate the desired range of motion.
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
Measured with a handheld dynamometer.
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
Measured using a hand-held dynamometer.
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
Measured using a hand-held dynamometer.
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
Measured using a hand-held dynamometer.
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
Measured using a hand-held dynamometer.
Time frame: 3 test occasions: baseline, 2 weeks after baseline and 4 weeks after baseline.
Measured using a hand-held dynamometer.
Time frame: This test will be carried out on the second test occasion (two weeks after baseline).
Maximal distance covered in 12 minutes.
Time frame: Baseline
Surveyed with an online questionnaire and quantified in hours/week (per sport performed).
Time frame: This test will be carried out on the third test occasion (four weeks after baseline).
Measures with an Optojump device
Time frame: This test will be carried out on the third test occasion (four weeks after baseline).
Measured using an Optojump device.
Time frame: This test will be carried out on the third test occasion (four weeks after baseline).
Measured using an Optojump device.
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
Measured using dual-energy X-ray absorptiometry and a tape measure.
Time frame: Baseline
Measured busing dual-energy X-ray absorptiometry.
Contact information is provided by the study sponsor or research team.
Vrije Universiteit Brussel
Other
Lower Limb Functional Asymmetry in Healthy Novice, Moderately and Highly-trained Distance Runners Versus Non-athletes
Acronym: ASYMRUN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686393
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT07669077
Healthy
Salt Lake City, Utah, United States
View Trial DetailsNCT07169630
Alzheimer s Disease, Cognition Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT07739238
Healthy
Balıkesir, In the USA Or Canada, Please Select..., Turkey (Türkiye)
View Trial Details